Overview
AZD6765 for Treatment Resistant Depression
Status:
Completed
Completed
Trial end date:
2007-11-01
2007-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether treatment with AZD6765 will have an antidepressant effect with patients who have treatment resistant depression.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AstraZeneca
Criteria
Inclusion Criteria:- Diagnosis of Depression
- Inadequate response to an adequate course of antidepressants
Exclusion Criteria:
- Psychiatric disorder other than depression
- Pregnancy or lactation
- Current diagnosis of cancer